110020 — Jeonjin Bio Co Income Statement
0.000.00%
Last trade - 00:00- KR₩22bn
- KR₩15bn
- KR₩19bn
Annual income statement for Jeonjin Bio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3,867 | 3,214 | 7,794 | 15,681 | 19,273 |
| Cost of Revenue | |||||
| Gross Profit | 2,216 | 1,363 | 2,006 | 4,870 | 6,052 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 6,032 | 6,244 | 10,847 | 17,489 | 18,349 |
| Operating Profit | -2,166 | -3,030 | -3,053 | -1,808 | 924 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -3,418 | -2,108 | -3,113 | -6,440 | 4,346 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -3,418 | -2,108 | -3,113 | -6,440 | 4,346 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -3,418 | -2,108 | -3,113 | -6,440 | 4,346 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -3,418 | -2,108 | -3,113 | -6,440 | 4,346 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -639 | -340 | -485 | -808 | 586 |
| Dividends per Share |